It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. While a well funded company may sustain losses for years, it will need to generate a profit eventually, or else investors will move on and the company will wither away.
So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like DMCC Speciality Chemicals (NSE:DMCC). Now this is not to say that the company presents the best investment opportunity around, but profitability is a key component to success in business.
How Fast Is DMCC Speciality Chemicals Growing Its Earnings Per Share?
In the last three years DMCC Speciality Chemicals' earnings per share took off; so much so that it's a bit disingenuous to use these figures to try and deduce long term estimates. So it would be better to isolate the growth rate over the last year for our analysis. DMCC Speciality Chemicals' EPS shot up from ₹11.19 to ₹16.03; a result that's bound to keep shareholders happy. That's a impressive gain of 43%.
One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. While we note DMCC Speciality Chemicals achieved similar EBIT margins to last year, revenue grew by a solid 50% to ₹7.1b. That's a real positive.
You can take a look at the company's revenue and earnings growth trend, in the chart below. For finer detail, click on the image.
View our latest analysis for DMCC Speciality Chemicals
DMCC Speciality Chemicals isn't a huge company, given its market capitalisation of ₹8.9b. That makes it extra important to check on its balance sheet strength.
Are DMCC Speciality Chemicals Insiders Aligned With All Shareholders?
Seeing insiders owning a large portion of the shares on issue is often a good sign. Their incentives will be aligned with the investors and there's less of a probability in a sudden sell-off that would impact the share price. So we're pleased to report that DMCC Speciality Chemicals insiders own a meaningful share of the business. Owning 48% of the company, insiders have plenty riding on the performance of the the share price. Those who are comforted by solid insider ownership like this should be happy, as it implies that those running the business are genuinely motivated to create shareholder value. To give you an idea, the value of insiders' holdings in the business are valued at ₹4.2b at the current share price. That should be more than enough to keep them focussed on creating shareholder value!
Is DMCC Speciality Chemicals Worth Keeping An Eye On?
For growth investors, DMCC Speciality Chemicals' raw rate of earnings growth is a beacon in the night. Further, the high level of insider ownership is impressive and suggests that the management appreciates the EPS growth and has faith in DMCC Speciality Chemicals' continuing strength. The growth and insider confidence is looked upon well and so it's worthwhile to investigate further with a view to discern the stock's true value. Don't forget that there may still be risks. For instance, we've identified 3 warning signs for DMCC Speciality Chemicals that you should be aware of.
Although DMCC Speciality Chemicals certainly looks good, it may appeal to more investors if insiders were buying up shares. If you like to see companies with more skin in the game, then check out this handpicked selection of Indian companies that not only boast of strong growth but have strong insider backing.
Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.